Rhythm Pharmaceuticals announces new grants to boost employment
Rhythm Pharmaceuticals, Inc. BOSTON, Aug. 13, 2024 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced that on August 8, 2024, the Compensation and Management Development Committee of Rhythm’s Board of Directors granted incentive restricted … Read more